ArticleFrontiers in oncology2021

TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia.

Maria Cristina Puzzolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.